Compare Stocks → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CXSENASDAQ:FDTNASDAQ:PPHNASDAQ:USAT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCXSEWisdomTree China ex-State-Owned Enterprises Fund$27.58+2.4%$26.35$23.29▼$34.74$375.93M0.57117,886 shs19,605 shsFDTFirst Trust Developed Markets ex-US AlphaDEX Fund$55.00+0.9%$54.81$46.90▼$56.65$409.20M0.9631,634 shs16,486 shsPPHVanEck Pharmaceutical ETF$86.80+0.3%$88.69$74.05▼$91.16$498.23M0.72132,669 shs616,575 shsUSATCantaloupe$5.80-1.4%$6.44$4.80▼$12.94$412.26M2.25291,261 shs394,427 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCXSEWisdomTree China ex-State-Owned Enterprises Fund+2.37%+7.99%+5.43%+9.23%-14.56%FDTFirst Trust Developed Markets ex-US AlphaDEX Fund+0.86%+2.06%-2.20%+6.03%+9.02%PPHVanEck Pharmaceutical ETF+0.32%+1.95%-4.50%+2.25%+10.80%USATCantaloupe-1.36%-5.84%-10.22%-13.17%+5.07%This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free CopyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCXSEWisdomTree China ex-State-Owned Enterprises FundN/AN/AN/AN/AN/AN/AN/AN/AFDTFirst Trust Developed Markets ex-US AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AUSATCantaloupeN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCXSEWisdomTree China ex-State-Owned Enterprises Fund0.00N/A$31.5714.45% UpsideFDTFirst Trust Developed Markets ex-US AlphaDEX Fund0.00N/A$52.52-4.51% DownsidePPHVanEck Pharmaceutical ETF0.00N/A$95.469.97% UpsideUSATCantaloupeN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCXSEWisdomTree China ex-State-Owned Enterprises FundN/AN/AN/AN/AN/AN/AFDTFirst Trust Developed Markets ex-US AlphaDEX FundN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AUSATCantaloupe$150.91M2.73N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCXSEWisdomTree China ex-State-Owned Enterprises FundN/AN/A12.70∞N/AN/AN/AN/AN/AFDTFirst Trust Developed Markets ex-US AlphaDEX FundN/AN/A7.05∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A20.57∞N/AN/AN/AN/AN/AUSATCantaloupeN/A-$0.48N/A∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCXSEWisdomTree China ex-State-Owned Enterprises Fund$0.481.74%N/AN/AN/AFDTFirst Trust Developed Markets ex-US AlphaDEX Fund$2.274.13%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.561.80%N/AN/AN/AUSATCantaloupeN/AN/AN/AN/AN/ALatest USAT, CXSE, PPH, and FDT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2024PPHVanEck Pharmaceutical ETF$0.53284/1/20244/2/20244/5/20243/20/2024FDTFirst Trust Developed Markets ex-US AlphaDEX FundQuarterly$0.19623/21/20243/22/20243/28/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCXSEWisdomTree China ex-State-Owned Enterprises FundN/AFDTFirst Trust Developed Markets ex-US AlphaDEX FundN/APPHVanEck Pharmaceutical ETFN/AUSATCantaloupe61.59%Insider OwnershipCompanyInsider OwnershipCXSEWisdomTree China ex-State-Owned Enterprises FundN/AFDTFirst Trust Developed Markets ex-US AlphaDEX FundN/APPHVanEck Pharmaceutical ETFN/AUSATCantaloupe18.80%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCXSEWisdomTree China ex-State-Owned Enterprises Fund147,00013.63 millionN/ANot OptionableFDTFirst Trust Developed Markets ex-US AlphaDEX Fund147,0007.44 millionN/ANot OptionablePPHVanEck Pharmaceutical ETF147,0005.74 millionN/AOptionableUSATCantaloupeN/A71.08 millionN/ANot OptionableUSAT, CXSE, PPH, and FDT HeadlinesSourceHeadlineTop 6 Best Bitter Melon Supplements in 2024straight.com - April 26 at 10:39 PMCantaloupe (NASDAQ:USAT) Research Coverage Started at StockNews.comamericanbankingnews.com - April 24 at 2:22 AMCantaloupe, Inc. (CTLP) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 16 at 12:26 AMWater Melon mandi prices in Karnatakacommodityonline.com - March 31 at 9:54 AMBenchmark Initiates Coverage of Cantaloupe (CTLP) with Buy Recommendationmsn.com - February 23 at 8:36 PMCantaloupe Stock (NASDAQ:CTLP), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 22 at 8:59 AMDr. Melon Negahealth.usnews.com - January 11 at 8:20 AMLatest salmonella outbreak recalls include whole cantaloupes and Walmart fruit dishessacbee.com - November 27 at 7:55 AMDozens sickened in cantaloupe recall; Ohio impactedfox8.com - November 22 at 7:35 PMBerenberg Initiates Coverage of Cantaloupe (CTLP) with Buy Recommendationmsn.com - October 3 at 7:58 PMCantaloupe recalled due to possible salmonella contaminationtoday.com - October 3 at 2:58 PMQ4 2023 Cantaloupe Inc Earnings Callfinance.yahoo.com - September 17 at 7:29 AMWhy Cantaloupe Stock Dropped Todaymsn.com - September 7 at 5:56 PMMelon Mania: Why Crown Melons Are the Most Luxurious Food to Eat Right Nowobserver.com - August 28 at 9:35 AMHealth Benefits of Honeydew Melonhealth.com - August 20 at 9:31 PMCantaloupe green smoothiemensjournal.com - July 22 at 8:42 AMCantaloupe Margaritaspbs.org - June 24 at 10:15 AMCantaloupe fined $1.5M in SEC accounting fraud casecomplianceweek.com - June 6 at 12:58 PMOhio festival guide 2023: from walleye to frogs, strawberries and meloncleveland.com - June 2 at 1:09 AMMultistate Outbreaks of Salmonella Serotype Poona Infections Associated With Eating Cantaloupe from Mexico - United States and Canada, 2000-2002medscape.com - May 2 at 10:02 AMQuite a few insiders invested in Cantaloupe, Inc. (NASDAQ:CTLP) last year which is positive news for shareholdersfinance.yahoo.com - April 26 at 7:38 PMWater Melon mandi pricescommodityonline.com - April 4 at 1:55 PMRoss Chastain helps remove wall at Martinsville Speedway to commemorate ‘Hail Melon’nascar.com - March 12 at 6:54 AMCantaloupe, Inc. (CTLP)uk.finance.yahoo.com - February 16 at 3:15 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsWisdomTree China ex-State-Owned Enterprises FundNASDAQ:CXSEThe WisdomTree China ex-State-Owned Enterprises Fund (CXSE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market-cap-weighted index of Chinese companies that are not state-owned, defined as government ownership of less than 20%. CXSE was launched on Sep 19, 2012 and is managed by WisdomTree.First Trust Developed Markets ex-US AlphaDEX FundNASDAQ:FDTThe First Trust Developed Markets Ex-US AlphaDEX Fund (FDT) is an exchange-traded fund that is based on the NASDAQ AlphaDEX DM Ex-US index. The fund tracks an index of international, developed-market stocks, selected by growth and value factors and equal-weighted in tiers. FDT was launched on Apr 18, 2011 and is managed by First Trust.VanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.CantaloupeNASDAQ:USATCantaloupe, Inc. is a software and payments company, which engages in the provision of end-to-end technology solutions for the unattended retail market. It offers Internet of Things (IoT) and machine-to-machine (M2M) services, which include the ability to remotely monitor, control, and report on the results of distributed assets containing the electronic payment solutions. The company was founded by George Raymond Jensen Jr. in January 1992 and is headquartered in Malvern, PA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.